The acquisition cost of bivalirudin is approximately $335 per vial, with 82% and 18% of patients needing only one and two vials in REPLACE-2, respectively ( Table 1). [11,36,37] This resulted in ...
Am J Health Syst Pharm. 2007;64(19):2017-2026. The safety of bivalirudin in patients with ACS and renal impairment was also examined in a large clinical database analysis. [43] Data from two Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback